Elvira Agrón

ORCID: 0000-0002-2829-4042
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Glaucoma and retinal disorders
  • Retinal and Optic Conditions
  • Ophthalmology and Visual Impairment Studies
  • Ocular Diseases and Behçet’s Syndrome
  • Antioxidant Activity and Oxidative Stress
  • melanin and skin pigmentation
  • Nutritional Studies and Diet
  • Connexins and lens biology
  • Retinal Development and Disorders
  • Neurological Disease Mechanisms and Treatments
  • Acute Ischemic Stroke Management
  • Ocular Oncology and Treatments
  • Intraocular Surgery and Lenses
  • Cerebral Venous Sinus Thrombosis
  • Cancer, Hypoxia, and Metabolism
  • Dye analysis and toxicity
  • Systemic Lupus Erythematosus Research
  • Hallucinations in medical conditions
  • Ophthalmology and Visual Health Research
  • Genetic Associations and Epidemiology
  • interferon and immune responses
  • Digital Imaging for Blood Diseases
  • Advanced Glycation End Products research

National Institutes of Health
2016-2025

National Eye Institute
2016-2025

Research Applications (United States)
2010-2022

Emmes (United States)
2009-2020

W.K. Kellogg Foundation
2020

University of Michigan–Ann Arbor
2020

George Washington University
2009

<h3>Importance</h3> The Age-Related Eye Disease Study (AREDS) formulation for the treatment of age-related macular degeneration (AMD) contains vitamin C, E, beta carotene, and zinc with copper. 2 (AREDS2) assessed value substituting lutein/zeaxanthin in AREDS because demonstrated risk lung cancer from carotene smokers former lutein zeaxanthin are important components retina. <h3>Objective</h3> To further examine effect supplementation on progression to late AMD. <h3>Design, Setting,...

10.1001/jamaophthalmol.2013.7376 article EN JAMA Ophthalmology 2014-02-01

Providing long-term follow-up of the natural history age-related macular degeneration (AMD) and associated risk factors will facilitate future epidemiologic studies clinical trials.

10.1001/jamaophthalmol.2013.6636 article EN JAMA Ophthalmology 2014-01-02
Emily Y. Chew Traci E. Clemons Elvira Agrón Amitha Domalpally Tiarnán D L Keenan and 92 more Susan Vitale Claire Weber Douglas C. Smith William G. Christen John Paul SanGiovanni Federick L Ferris Ronald P. Danis Barbara A. Blodi Alan Ruby Andrew N. Antoszyk Ronald Klein Ivana K. Kim Gary E. Fish Wai T. Wong David H. Orth Kourous A. Rezaei Susan B. Bressler GB Hubbard Michael J. Elman Suresh Chandra Thomas R. Friberg Michael Tolentino Darmakusuma Le Mary B. Lansing Jay B. Stallman Paul Edwards Carl W. Baker Michael Novák Ricky D. Isernhagen Todd E. Schneiderman Lawrence S. Halperin Michael H. Lee David S. Boyer Philip J. Rosenfeld Pamela Rath Marc H. Levy Robert H. Rosa John C. Hoskins Clement K. Chan David M. Brown Craig M. Greven J Michael Jumper Linda J. Margulies William N. Rosenthal Richard B. Rosen Glenn Stoller Fadi El Baba W. Copley McLean Ronald Kingsley Alice T. Lyon Jeffrey S. Heier Anne E. Fung Ingrid U. Scott John A. Wells Michael J. Banach Paul M. Beer James C. Folk Joseph I. Maguire Srinivas R. Sadda Richard A. Garfinkel Judy E. Kim Paul Berstein Michael Rauser Richard A. Lewis Barron C. Fishburne Susan S. Huang Nelson R. Sabates Nicola Kim Robert N. Frank Brian C. Joondeph Odette M. Houghton Dean P. Hainsworth Edward Chaum Robert H. Millay Raymond Iezzi Rajendra S. Apte Ron A. Adelman Anita Agrawal Neelakshi Bhagat Lawrence Ulanski Steven D. Schwartz Cynthia Owsley Alan Letson Yu-Guang He Cynthia A. Toth Lawrence S. Morse Michael J. Cooney Sandeep Grover Henry Ferreyra Alexander J. Brucker David DiLoreto Aaron Weinberg

After the Age-Related Eye Disease Study 2 (AREDS2) study, beta carotene component was replaced by lutein/zeaxanthin for development of revised AREDS supplement. However, it is unknown if increased risk lung cancer observed in those assigned persists beyond conclusion AREDS2 trial and there a benefit adding to original supplement that can be with long-term follow-up.To assess 10-year developing late age-related macular degeneration (AMD).This multicenter epidemiologic follow-up study clinical...

10.1001/jamaophthalmol.2022.1640 article EN JAMA Ophthalmology 2022-06-02

OBJECTIVE—Diabetes is a leading cause of morbidity and mortality. The purpose this study to assess the associations between diabetes complications mortality in Early Treatment Diabetic Retinopathy Study (ETDRS). RESEARCH DESIGN AND METHODS—We examined demographic, clinical, laboratory characteristics 3,711 subjects enrolled ETDRS, randomized controlled clinical trial designed evaluate role laser photocoagulation aspirin therapy for diabetic retinopathy. outcome assessed was all-cause...

10.2337/diacare.28.3.617 article EN Diabetes Care 2005-03-01

<h3>Importance</h3> Observational data have suggested that high dietary intake of saturated fat and low vegetables may be associated with increased risk Alzheimer disease. <h3>Objective</h3> To test the effects oral supplementation nutrients on cognitive function. <h3>Design, Setting, Participants</h3> In a double-masked randomized clinical trial (the Age-Related Eye Disease Study 2 [AREDS2]), retinal specialists in 82 US academic community medical centers enrolled observed participants who...

10.1001/jama.2015.9677 article EN JAMA 2015-08-25

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly population worldwide. Although recent studies have demonstrated strong genetic associations between AMD and SNPs a number genes, other modes regulation are also likely to play role etiology this disease. We identified significantly decreased level methylation on IL17RC promoter patients. Furthermore, we showed that hypomethylation patients led an elevated expression its protein messenger RNA...

10.1016/j.celrep.2012.10.013 article EN cc-by-nc-nd Cell Reports 2012-11-01

Age related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly populations worldwide. Inflammation, among many factors, has been suggested to play an important role AMD pathogenesis. Recent studies have demonstrated a strong genetic association between and complement factor H (CFH), down-regulatory activation. Elevated levels activating molecules including component 5a (C5a) found serum patients. Our aim study whether C5a can impact human T cells its...

10.1186/1479-5876-9-111 article EN cc-by Journal of Translational Medicine 2011-07-15
Tiarnán D L Keenan Elvira Agrón Amitha Domalpally Traci E. Clemons Freekje van Asten and 95 more Wai T. Wong Ronald Danis Srinivas R. Sadda Philip J. Rosenfeld Michael L. Klein Rinki Ratnapriya Anand Swaroop Frederick L. Ferris Emily Y. Chew Emily Y. Chew Frederick L. Ferris John Paul SanGiovanni Elvira Agrón Traci E. Clemons Anne S. Lindblad Robert Lindblad Nilay S. Shah Robert D. Sperduto Wendy L. McBee Gary Gensler Molly Harrington Alice Henning Katrina Jones Kumar Thotapally Diana Tull Valerie Watson Kayla Williams Christina Gentry Francine Kaufman Christopher N. Morrison Elizabeth Saverino Sherrie Schenning Barbara Blodi Ronald P. Danis Matthew Davis Amitha Domalpally Kathy Glander Gregory Guilfoil Larry D. Hubbard Kristine A. Johnson Ronald Klein Barbara Nardi Michael W. Neider N. Edward Robinson Eileen Rosensteel Hugh Wabers Grace Zhang Alan Ruby Antonio Capone Bawa Dass Kimberly A. Drenser Bruce R. Garretson T. Hassan Michael T. Trese George A. Williams Jeremy D. Wolfe Tina Bell Mary Zajechowski Dennis Bezaire Fran McIver Anthony Medina Jackie Pagett Stephanie Hatch Smith Lynn Swartz Tom Treuter Andrew N. Antoszyk Justin C. Brown David J. Browning Walter Holland Angella S. Karow Kelly Stalford Angela Price Sarah Ennis Sherry L. Fredenberg Jenna Herby Uma Balasubramaniam Loraine Clark Donna McClain Michael McOwen Lynn Watson Michael L. Klein Steven T. Bailey Thomas J. Hwang Andreas Lauer J. Timothy Stout Patty McCollum Milt Johnson Patrick B. Rice Ivana K. Kim John I. Loewenstein Joan W. Miller Lucia Sobrin Lucy H. Young Jacqueline Sullivan Patricia Houlihan

10.1016/j.ophtha.2018.05.028 article EN publisher-specific-oa Ophthalmology 2018-07-27

To characterize changes in macular sensitivity during geographic atrophy (GA) progression using microperimetry.Retinal the area was evaluated by microperimetry 10 patients with bilateral GA, adequate data obtained 9 of (n = 18 eyes). Patients had been enrolled an interventional trial which one eye randomized to treatment and other observed. No effect regard GA growth microperimetric measurements detected, all eyes were analyzed. Microperimetric assessments central 20° macula performed every...

10.1167/iovs.10-6075 article EN Investigative Ophthalmology & Visual Science 2010-10-06

Age-related macular degeneration (AMD), a chronic neurodegenerative and neovascular retinal disease, is the leading cause of blindness in elderly people western European origin. While structural functional alterations mitochondria (mt) their metabolites have been implicated pathogenesis vascular diseases, relationship inherited variants mitochondrial genome mt haplogroup subtypes with advanced AMD has not reported large prospective cohorts.We examined mtDNA 1168 using three-stage design on...

10.1371/journal.pone.0005508 article EN cc-by PLoS ONE 2009-05-11
Coming Soon ...